http://www.theaustralian.com.au/business/the-next-must-buy-biotech-is-anyones-guess/story-e6frg8zx-1226038022541
Article about good Biotech stocks to invest in. Small paragraph that states -
"You could run a line through the top 20 biotech companies and most are targets in one way or the other," says RBS Morgans biotech analyst Scott Power.
Power says "there will be a few more (deals) emerging over the next little while."
He says it's possible that Acrux's new partner Eli Lilly will bid for the company holus-bolus.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.524M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $19.90K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 463664 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 320000 | 2 |
View Market Depth
| Last trade - 15.56pm 25/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |